Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Veterans Affairs Medical Center
mi
from
Lexington, KY
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Veterans Affairs Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
University of Kentucky Chandler Medical Center
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
St. Mary's of Michigan
mi
from
Saginaw, MI
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
St. Mary's of Michigan
mi
from
Saginaw, MI
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Covenant Medical Center
mi
from
Saginaw, MI
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Covenant Medical Center
mi
from
Saginaw, MI
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Viahealth Rochester General Hospital
mi
from
Rochester, NY
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Viahealth Rochester General Hospital
mi
from
Rochester, NY
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Brody School of Medicine at East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Cardiac, Vascular, & Thoracic Surgeons, Inc.
mi
from
Cincinnati, OH
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Cardiac, Vascular, & Thoracic Surgeons, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Good Samaritan Hospital
mi
from
Cincinnati, OH
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Good Samaritan Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Bethesda North Hospital
mi
from
Cincinnati, OH
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Bethesda North Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Oklahoma Cardiovascular Associates
mi
from
Oklahoma City, OK
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Oklahoma Cardiovascular Associates
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Oklahoma Cardiovascular Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
CardioThoracic Surgery Center, PLC
mi
from
Jackson, TN
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
CardioThoracic Surgery Center, PLC
mi
from
Jackson, TN
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Jackson Madison County General Hospital
mi
from
Jackson, TN
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Jackson Madison County General Hospital
mi
from
Jackson, TN
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Centennial Medical Center
mi
from
Nashville, TN
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Methodist Hospital
mi
from
Houston, TX
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Winchester Medical Center
mi
from
Winchester, VA
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Winchester Medical Center
mi
from
Winchester, VA
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
FHS Research Center, St. Joseph Medical Center
mi
from
Tacoma, WA
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
FHS Research Center, St. Joseph Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated:  11/17/2016
Northwest Cardiovascular Associates
mi
from
Tacoma, WA
Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Grafting (CABG) Involving Cardiopulmonary Bypass
Randomized, Multicenter, Placebo-Controlled, Double-Blind, Parallel Group Study of INS50589 Intravenous Infusion in Subjects Undergoing Coronary Artery Bypass Graft Surgery Involving Cardiopulmonary Bypass
Status: Enrolling
Updated: 11/17/2016
Northwest Cardiovascular Associates
mi
from
Tacoma, WA
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Minneapolis Medical Research Foundation
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Columbia University
mi
from
New York, NY
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Wake Forest University
mi
from
Winston-Salem, NC
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Veterans Affairs
mi
from
Memphis, TN
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Veterans Affairs
mi
from
Memphis, TN
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
Univ of Washington
mi
from
Seattle, WA
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated:  11/21/2016
McMaster University
mi
from
Hamilton,
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Status: Enrolling
Updated: 11/21/2016
McMaster University
mi
from
Hamilton,
Click here to add this to my saved trials
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
A Phase 1 Multicenter Open Label Safety and Tolerability Clinical Trial of Ciliary Neurotrophic Factor (CNTF) in Patients With Macular Telangiectasia Type 2 (Mactel)
Status: Enrolling
Updated:  11/21/2016
Jules Stein Eye Institute
mi
from
Los Angeles, CA
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
A Phase 1 Multicenter Open Label Safety and Tolerability Clinical Trial of Ciliary Neurotrophic Factor (CNTF) in Patients With Macular Telangiectasia Type 2 (Mactel)
Status: Enrolling
Updated: 11/21/2016
Jules Stein Eye Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
A Phase 1 Multicenter Open Label Safety and Tolerability Clinical Trial of Ciliary Neurotrophic Factor (CNTF) in Patients With Macular Telangiectasia Type 2 (Mactel)
Status: Enrolling
Updated:  11/21/2016
Retina Associates of Cleveland
mi
from
Cleveland, OH
Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)
A Phase 1 Multicenter Open Label Safety and Tolerability Clinical Trial of Ciliary Neurotrophic Factor (CNTF) in Patients With Macular Telangiectasia Type 2 (Mactel)
Status: Enrolling
Updated: 11/21/2016
Retina Associates of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
An Open Label, Randomized, Single Dose, Crossover Study to Determine the Pharmacokinetics of Three Tablet Formulations of GSK2798745 in Healthy Subjects
Status: Enrolling
Updated:  11/21/2016
GSK Investigational Site
mi
from
Overland Park, KA
A Phase I Study to Assess the Pharmacokinetics of GSK2798745 Tablets
An Open Label, Randomized, Single Dose, Crossover Study to Determine the Pharmacokinetics of Three Tablet Formulations of GSK2798745 in Healthy Subjects
Status: Enrolling
Updated: 11/21/2016
GSK Investigational Site
mi
from
Overland Park, KA
Click here to add this to my saved trials
Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
Status: Enrolling
Updated:  11/22/2016
Retina Consultants of Hawaii
mi
from
Aiea, HI
Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
Status: Enrolling
Updated: 11/22/2016
Retina Consultants of Hawaii
mi
from
Aiea, HI
Click here to add this to my saved trials
The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery
Status: Enrolling
Updated:  11/22/2016
Duke University
mi
from
Durham, NC
The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery
Status: Enrolling
Updated: 11/22/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
Status: Enrolling
Updated:  11/22/2016
University of Missouri
mi
from
Columbia, MO
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
Characterization of Sympathetic Nerve Activity in Stress Cardiomyopathy
Status: Enrolling
Updated: 11/22/2016
University of Missouri
mi
from
Columbia, MO
Click here to add this to my saved trials
Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
Treatment of Choroidal Subretinal Neovascularization With Agents Directed Against the Immune Response
Status: Enrolling
Updated:  11/28/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration
Treatment of Choroidal Subretinal Neovascularization With Agents Directed Against the Immune Response
Status: Enrolling
Updated: 11/28/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Emory University School of Medicine
mi
from
Atlanta, GA
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Tufts Medical Center
mi
from
Boston, MA
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Massachusetts General Hospital
mi
from
Boston, MA
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Boston VA Healtcare System
mi
from
West Roxbury, MA
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Boston VA Healtcare System
mi
from
West Roxbury, MA
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
The Mayo Clinic
mi
from
Rochester, MN
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Washington University
mi
from
St. Louis, MO
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Saint Louis University Hospital
mi
from
St. Louis, MO
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Saint Louis University Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Duke University
mi
from
Durham, NC
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Southeastern Regional Medical Center
mi
from
Lumberton, NC
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Southeastern Regional Medical Center
mi
from
Lumberton, NC
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Metro Health System
mi
from
Cleveland, OH
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Metro Health System
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Cleveland Clinic
mi
from
Cleveland, OH
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated:  11/29/2016
Lancaster General Hospital
mi
from
Lancaster, PA
Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy - HF (ATHENA-HF)
Status: Enrolling
Updated: 11/29/2016
Lancaster General Hospital
mi
from
Lancaster, PA
Click here to add this to my saved trials